Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1379 of 5804
-
New therapy aims to retrain the brain to stop fake seizures
Symptom relief Recruiting nowThe purpose of this study is to assess sense of control and catastrophic symptom expectations as targets for Retraining and Control Therapy (ReACT- an intervention focused on changing behaviors and thoughts) for treatment of pediatric psychogenic non-epileptic seizures (PNES, epi…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Smart pacifier aims to boost speech development in preterm infants
Symptom relief Recruiting nowThe goal of this clinical study is to test a new, novel medical device designed to improve speech sound differentiation among hospitalized preterm infants. The device is designed to be used at an age equivalent to 32 weeks of gestation or older and to integrate readily into clini…
Phase: NA • Sponsor: Thrive Neuromedical, LLC • Aim: Symptom relief
Last updated Jun 26, 2026 15:54 UTC
-
New hope for Hard-to-Treat prostate cancer: first human trial launches
Disease control OngoingProstate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men worldwide. The purpose of this study is to assess safety, pharmacokinetics, and efficacy of ABBV-969 as a monotherapy. ABBV-969 is an investigational drug bein…
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
HIIT may shield breast cancer Survivors' hearts from chemo damage
Disease control Recruiting nowChemotherapy is an effective breast cancer treatment, which helped to increase the 5-year survival rate to approximately 95%. However, breast cancer survivors have a higher risk of cardiovascular disease (CVD) due to chemotherapy than adults without cancer. Cardiovascular rehabil…
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Virus injection aims to stop melanoma before it spreads
Disease control Recruiting nowThis early-phase study will examine Vusolimogene Oderparepvec, a genetically modified oncolytic viral strain of the herpes simplex type 1 (HSV-1) virus, with potential oncolytic, immunostimulating and antineoplastic activities. Upon administration, vusolimogene oderparepvec speci…
Phase: EARLY_PHASE1 • Sponsor: Yana Najjar • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can online therapy calm heart attack survivors' fears?
Symptom relief Recruiting nowThe aim of this study is to evaluate if an online Cognitive Behavioral Therapy (CBT) protocol customized for patients following Acute Coronary Syndrome (ACS), reduce cardiac anxiety, enhance Quality of Life (QoL), and promote increased physical activity while controlling for care…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 26, 2026 18:21 UTC
-
New hope for kids with tough leukemia: oral drug combo enters human testing
Disease control Recruiting nowTo find a recommended dose of ASTX727 (cedazuridine/decitabine) in combination with venetoclax for pediatric patients with relapsed AML.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New biomarker model aims to reduce unnecessary lung biopsies
Diagnosis OngoingThis is a prospective, multicenter observational study aim at estimating the potential clinical utility of the CBM and at establishing the SOPs and protocols for a future randomized control trial.
Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Real-World data shows promise for breast cancer combo therapy
Disease control CompletedThis is a non-interventional, ambispective, observational cohort study describing the real-world safety data of approximately 550 Hormone receptor / Human epidermal growth factor receptor 2 (HR+/HER2-) advanced/metastatic breast cancer patients who have received ribociclib combin…
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Smart scans guide Ultra-Precise radiation for tough prostate cancers
Disease control Recruiting nowSequential cohort evaluation of ideal timing of imaging and treatment spacing to discern maximal PSMA (Prostate specific membrane antigen) PET (Positron Emission Tomography) response (PSMA-11 68Ga, Illucix) for adaptation of dominant intra-prostatic lesion tumor boost dose
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Can targeted brain zaps ease months of Post-Concussion struggles?
Symptom relief Recruiting nowThe goal of this study is to investigate a new treatment for chronic symptoms after concussion or mild traumatic brain injury in people aged 18-65 years old. Chronic symptoms could include dizziness, headache, fatigue, brain fog, memory difficulty, sleep disruption, irritability,…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New drug MGC026 takes on advanced cancers in first human trial
Disease control Recruiting nowThe study is designed to understand the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary antitumor activity of MGC026 in participants with relapsed or refractory, unresectable, locally advanced or metastatic solid tumors The study has a dose escalation port…
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Zapping the brain while talking: a new way to break the worry cycle?
Symptom relief Recruiting nowThis study aims to investigate whether the combination of transcranial Direct Current Stimulation (tDCS) and cognitive-behavioral therapy (CBT) is more effective for treating repetitive negative thinking (RNT) in patients with the symptom of high rumination. High ruminators will …
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New implant aims to open blocked urinary flow without daily pills
Disease control OngoingThe purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.
Phase: NA • Sponsor: ProVerum Medical • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Home breathing aid for ALS: just as good as hospital?
Symptom relief Recruiting nowThis research will study whether noninvasive ventilation (NIV) used to treat chronic respiratory insufficiency in patients with amyotrophic lateral sclerosis (ALS) can be initiated as successfully in the outpatient setting as in the conventional inpatient setting, and what the co…
Phase: NA • Sponsor: Tampere University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Supercharged immune cells take on Hard-to-Treat myeloma
Disease control CompletedThis phase I trial tests the side effects and best dose of TGFbi natural killer (NK) cells (TiNK) when given together with isatuximab for the treatment of patients with multiple myeloma that has come back after a period of improvement (relapsed) or that has not responded to treat…
Phase: PHASE1 • Sponsor: Elvira Umyarova • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New weekly shot aims to curb obesity in rare genetic disorders
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, and PK of RM-718 in healthy subjects with obesity and in patients with MC4R Pathway Impairment
Phase: PHASE1, PHASE2 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New cancer drug shows promise in early trial
Disease control OngoingThe purpose of this study is to find out whether the study drug, LY4101174, is safe, tolerable and effective in participants with select advanced or metastatic solid tumors. The study is conducted in two parts - phase 1a (dose-escalation, dose-optimization) and phase 1b (dose-exp…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Brain zaps and ancient exercise join forces to fight knee pain
Symptom relief Recruiting nowThis study will combine brain imaging and neuromodulation tools to investigate the underlying neurobiological mechanisms of exercises. The findings will enhance our understanding of the mechanisms underlying mind-body exercise and facilitate the development of new pain management…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedLASN01 is a novel, fully human antibody directed against the human IL-11 receptor being developed for treatment of patients with thyroid eye disease (TED). The primary and secondary objectives of this study are to evaluate the treatment effect, safety, and pharmacokinetics of LA…
Phase: PHASE2 • Sponsor: Lassen Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC